Baclofen toxicity: Difference between revisions
Benalexander (talk | contribs) |
Benalexander (talk | contribs) |
||
| Line 38: | Line 38: | ||
*Activated charcoal for recent ingestion | *Activated charcoal for recent ingestion | ||
*Supportive care: | *Supportive care: | ||
**IV fluids | **Respiratory support | ||
**IV fluids | |||
**Vasopressors for persistent hypotension | **Vasopressors for persistent hypotension | ||
**Benzodiazepines for seizures | **Benzodiazepines for seizures or severe myoclonus | ||
***CNS depressive effects of benzodiazepines will be increased | |||
***Use the lowest effective dose and be prepared for respiratory depression | |||
*[[Hemodialysis/Hemoperfusion|Hemodialysis]] for very severe toxicity | *[[Hemodialysis/Hemoperfusion|Hemodialysis]] for very severe toxicity | ||
**Probably not beneficial in patients with normal renal function | |||
*For patients with intrathecal pump: | |||
**Consult managing specialist | |||
**Turn off pump | |||
**Can remove baclofen from pump reservoir and replace with normal saline | |||
**Consider large volume CSF removal via [[lumbar puncture]] to reduce level | |||
==Disposition== | ==Disposition== | ||
Revision as of 16:31, 13 October 2025
Background
- Baclofen is a synthetic derivative of GABA used to reduce spasticity in conditions such as multiple sclerosis and cerebral palsy, or to reduce muscular spasm in lower back pain.
- May also be used for hiccups and alcohol use disorder
- At therapeutic doses, baclofen acts as a GABA-B receptor agonist in the spinal cord, causing inhibition of muscular tone.
- At higher doses, baclofen loses selectivity and can cause sedation.
- Primarily (80%) excreted by the kidneys
- Dosage must be reduced in renal dysfunction and should be avoided with GFR < 30 mL/min/1.73 m2.
- Patients on chronic therapy may become toxic with new AKI.
Clinical Features
- Nausea and vomiting
- Depressed level of consciousness
- Delirium
- Seizures
- Tonic-clonic
- Non-convulsive status epilepticus
- Myoclonus
- Airway compromise and respiratory failure
- Hypothermia
- Hypotension
- Bradycardia and conduction abnormalities
Differential Diagnosis
Sedative/hypnotic toxicity
- Absinthe
- Barbiturates
- Benzodiazepines
- Chloral hydrate
- Gamma hydroxybutyrate (GHB)
- Baclofen toxicity
- Opioids
- Toxic alcohols
- Xylazine toxicity
Also consider co-ingestion with intentional overdose
Evaluation
- Diagnosis of exclusion, based on history
- Baclofen level can be measured but is not clinically useful
- In patients with intrathecal baclofen pump:
- Obtain KUB to evaluate pump tubing integrity and placement
- Consult the managing specialist to interrogate pump
Management
- Activated charcoal for recent ingestion
- Supportive care:
- Respiratory support
- IV fluids
- Vasopressors for persistent hypotension
- Benzodiazepines for seizures or severe myoclonus
- CNS depressive effects of benzodiazepines will be increased
- Use the lowest effective dose and be prepared for respiratory depression
- Hemodialysis for very severe toxicity
- Probably not beneficial in patients with normal renal function
- For patients with intrathecal pump:
- Consult managing specialist
- Turn off pump
- Can remove baclofen from pump reservoir and replace with normal saline
- Consider large volume CSF removal via lumbar puncture to reduce level
Disposition
See Also
References
- Jung, M. “Baclofen Overdoses”. Maryland Poison Center, University of Maryland School of Pharmacy. www.mdpoison.com Accessed April 29th, 2014.
- Nicola Y Leung, Ian M Whyte, Geoffrey K Isbister Baclofen overdose: defining the spectrum of toxicity. Emerg Med Australas: 2006, 18(1);77-82
